header_eight_logo
  • Contact
  • Resources
    • Compliance News
    • Webinar
    • Blog
  • Country
    • India

Blogs, Compliance News & more

Home The Compliance News COVID-19 Sri Lanka awaiting regulatory approval of molnupiravir anti-COVID drug – Economy Next

Sri Lanka awaiting regulatory approval of molnupiravir anti-COVID drug – Economy Next

Published On - November 12, 2021

srilanka COVID-19, The Compliance News
View Pdf

Sri Lanka awaiting regulatory approval of molnupiravir anti-COVID drug – Economy Next

Tags: COVID19, NOV21, The Compliance News

Post navigation

Strict guidelines during festive season – Daily Mirror.LK
Notification regarding Rates of Exchange effective from 15.11.2021 (Dated – 15.11.2021) – Dept. of Customs

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Sri Lanka Central Bank maintains its policy interest rates at current levels-Colombo Page May 20, 2022
  • CB expects middle spot exchange rate to strengthen rupee exchange rate – Dailymirror.LK May 20, 2022
  • Notice regarding Making Payments and Furnishing Returns for the month of April 2022 (dated – 18.05.2022) – Inland Revenue Department May 20, 2022
  • Notice regarding Online Tax Payment Platform (OTPP) (dated-17.05.2022) – Inland Revenue Department May 20, 2022
  • Notification regarding Rates of Exchange effective from 16.05.2022 (dated – 16.05.2022) – Dept. of Customs May 20, 2022

Categories

  • Blog
  • The Compliance News
    • COVID-19
    • Environment Health & Safety Laws
    • Fiscal Corporate & Commercial Laws
    • General
    • Labour Employment & Industrial Laws
  • Uncategorized

Logo

Logo Logo Logo

Country Partner

          Logo

Business Queries

Contact
+94 (76)-910-7778
+94(0)772 680 226
Mail
minel@3rdwaveconsulting.com
sithum@3rdwave.lk

© 2021 Compfie.comSrilanka. All Rights Reserved.